Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop.

Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop.

Item
http://www.wikidata.org/entity/Q37660800
Recent Progress towards Novel EV71 Anti-Therapeutics and VaccinesAn H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.Bioinformatic analysis of non-VP1 capsid protein of coxsackievirus A6.Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activityIn vivo time-related evaluation of a therapeutic neutralization monoclonal antibody against lethal enterovirus 71 infection in a mouse model.Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody.Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA.A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.Different Antibody Response against the Coxsackievirus A16 VP1 Capsid Protein: Specific or Non-Specific.Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients.EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challengeDevelopment of an Ad5H3 Chimera Using the "Antigen Capsid-Incorporation" Strategy for an Alternative Vaccination Approach.Enzyme-free colorimetric determination of EV71 virus using a 3D-MnO2-PEG nanoflower and 4-MBA-MA-AgNPs.Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children.Serological survey of neutralizing antibodies to eight major enteroviruses among healthy population.Enterovirus A71 Proteins: Structure and Function.Etiology, pathogenesis, antivirals and vaccines of hand, foot, and mouth disease
P2860

Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop.

Item
http://www.wikidata.org/entity/Q37660800
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protection against lethal ente ...... pitope within the VP2 EF loop.
@en
Protection against lethal ente ...... pitope within the VP2 EF loop.
@nl
type
label
Protection against lethal ente ...... pitope within the VP2 EF loop.
@en
Protection against lethal ente ...... pitope within the VP2 EF loop.
@nl
prefLabel
Protection against lethal ente ...... pitope within the VP2 EF loop.
@en
Protection against lethal ente ...... pitope within the VP2 EF loop.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Protection against lethal ente ...... epitope within the VP2 EF loop
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932